Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2014; 20(14): 3986-4000
Published online Apr 14, 2014. doi: 10.3748/wjg.v20.i14.3986
Published online Apr 14, 2014. doi: 10.3748/wjg.v20.i14.3986
Table 1 Distribution and frequency of the underlying liver disease of 143 liver transplant recipients
| Indication for transplantation | n (%) |
| Autoimmune etiology | 65 (45.5) |
| Primary sclerosing cholangitis | 44 (30.8) |
| Primary biliary cirrhosis | 14 (9.8) |
| Autoimmune hepatitis | 7 (4.9) |
| Viral hepatitis | 20 (13.9) |
| Hepatitis B | 5 (3.5) |
| Hepatitis C | 15 (10.5) |
| Other indications | 65 (43.9) |
| Hepatocellular carcinoma | 13 (8.8) |
| Secondary liver tumours | 7 (4.7) |
| Acute hepatic failure | 8 (5.4) |
| Alcoholic cirrhosis | 17 (12.2) |
| Cholangiocarcinoma | 10 (6.8) |
| Budd-Chiari | 2 (1.4) |
| Cryptogenic cirrhosis | 9 (6.1) |
| Metabolic liver disease | 1 (0.5) |
| Polycystic liver disease | 2 (1.4) |
- Citation: Fosby B, Næss S, Hov JR, Traherne J, Boberg KM, Trowsdale J, Foss A, Line PD, Franke A, Melum E, Scott H, Karlsen TH. HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation. World J Gastroenterol 2014; 20(14): 3986-4000
- URL: https://www.wjgnet.com/1007-9327/full/v20/i14/3986.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i14.3986